In a co-authored article for Managed Healthcare Executive, Faegre Drinker Consulting Principal Mike Adelberg — along with Blue Cross and Blue Shield of Minnesota’s Amy Fendrich, MD, FACP, and Ceresti’s Dirk Soenksen — describes how telehealth programs can better support caregivers of patients with Alzheimer’s Disease and Related Dementias (ADRD), increase quality of life and lower costs.
The authors detail how, by some estimates, ADRD is the costliest disease in the U.S., totaling more than $300 billion in annual Medicare/Medicaid costs and growing. Further, the COVID-19 pandemic has increased the demands placed on caregivers of ADRD patients.
However, the authors highlight telehealth interventions, including integrated care and support programs, as a promising means of cost-effectively and remotely supporting family caregivers with personalized education, resources and remote coaching.
In conclusion, the authors note how Medicare Advantage and Managed Long-Term Services and Supports plans, as well as Accountable Care Organizations and other providers incented to manage ADRD successfully, have new opportunities to leverage telehealth to empower and support caregivers to improve outcomes and lower costs for people with ADRD.